Published in Allergy on October 18, 2007
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov (2008) 4.76
Adenosine signaling and the regulation of chronic lung disease. Pharmacol Ther (2009) 1.14
Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease. Trends Pharmacol Sci (2009) 0.95
Adenosine receptors and asthma in humans. Br J Pharmacol (2008) 0.93
Adenosine receptors and asthma. Handb Exp Pharmacol (2009) 0.93
G protein-coupled receptors as therapeutic targets for multiple sclerosis. Cell Res (2012) 0.90
Treating lung inflammation with agonists of the adenosine A2A receptor: promises, problems and potential solutions. Br J Pharmacol (2008) 0.83
Gs-coupled adenosine receptors differentially limit antigen-induced mast cell activation. J Pharmacol Exp Ther (2012) 0.76
A2A adenosine receptor agonists for the treatment of asthma? Allergy (2008) 0.75
Adenosine influences myeloid cells to inhibit aeroallergen sensitization. Am J Physiol Lung Cell Mol Physiol (2016) 0.75
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med (1997) 8.48
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J (1995) 7.03
Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med (1999) 4.65
Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma. Thorax (1999) 4.11
Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J (2005) 3.66
Air pollution and development of asthma, allergy and infections in a birth cohort. Eur Respir J (2007) 3.42
A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16
A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group. N Engl J Med (1992) 3.13
Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Thorax (1999) 3.00
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med (2016) 2.89
Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax (2004) 2.85
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial. Lancet (2001) 2.68
Asthma at 8 years of age in children born by caesarean section. Thorax (2008) 2.45
PC(20) adenosine 5'-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine. Am J Respir Crit Care Med (2001) 2.36
Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction. Am Rev Respir Dis (1986) 2.29
Ciclesonide improves measures of small airway involvement in asthma. Eur Respir J (2008) 2.23
Severe exacerbations predict excess lung function decline in asthma. Eur Respir J (2007) 2.18
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine. Am J Respir Crit Care Med (2001) 2.08
Inhaled corticosteroids in COPD: a case in favour. Eur Respir J (2009) 2.06
[Comments on screening spirometry for detection of COPD]. Ned Tijdschr Geneeskd (2007) 2.06
The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J (2004) 2.05
Decline of FEV1 by age and smoking status: facts, figures, and fallacies. Thorax (1997) 2.04
Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax (2000) 2.02
Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med (2001) 1.99
Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Thorax (1992) 1.98
Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med (1999) 1.96
Effects of long-term treatment with corticosteroids in COPD. Chest (1996) 1.94
Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home. Eur Respir J (1994) 1.91
Childhood factors associated with asthma remission after 30 year follow up. Thorax (2004) 1.90
Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study. Eur Respir J (2007) 1.90
Reliability and validity of the chronic respiratory questionnaire (CRQ). Thorax (1994) 1.84
Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics (1994) 1.81
Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet (2000) 1.78
Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide. J Rheumatol (1993) 1.71
Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma. Allergy (2010) 1.70
Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol (2001) 1.65
Influence of the parasympathetic and sympathetic nervous system on nocturnal bronchial obstruction. Clin Sci (Lond) (1985) 1.64
Major genes regulating total serum immunoglobulin E levels in families with asthma. Am J Hum Genet (2000) 1.63
Exhaled nitric oxide in 4-year-old children: relationship with asthma and atopy. Eur Respir J (2005) 1.62
Relation between duration of smoking cessation and bronchial inflammation in COPD. Thorax (2005) 1.60
No effects of high-dose omeprazole in patients with severe airway hyperresponsiveness and (a)symptomatic gastro-oesophageal reflux. Eur Respir J (1998) 1.60
Particle size matters: diagnostics and treatment of small airways involvement in asthma. Eur Respir J (2010) 1.58
The Dutch hypothesis (chronic non-specific lung disease) revisited. Eur Respir J (1991) 1.57
Assessment of airway inflammation: an overview. Eur Respir J Suppl (1998) 1.55
Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma. Clin Exp Allergy (2004) 1.55
Long-term outcome of lung transplantation is predicted by the number of HLA-DR mismatches. Transplantation (2001) 1.55
Changes in respiratory symptoms and airway hyperresponsiveness after 27 years in a population-based sample of school children. Eur Respir J (1993) 1.54
Influence of in vivo prednisolone on increased in vitro O2- generation by neutrophils in emphysema. Eur Respir J (1993) 1.54
Relation of sputum colour to bacterial load in acute exacerbations of COPD. Respir Med (2008) 1.54
Childhood overweight and asthma symptoms, the role of pro-inflammatory proteins. Clin Exp Allergy (2011) 1.52
Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study. Am J Respir Crit Care Med (1999) 1.52
Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax (2003) 1.51
Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax (1994) 1.51
Pesticides and other occupational exposures are associated with airway obstruction: the LifeLines cohort study. Occup Environ Med (2013) 1.50
Conventional RIA underestimates cortisol suppression in the presence of prednisolone. Thorax (2002) 1.50
Less small airway dysfunction in asymptomatic bronchial hyperresponsiveness than in asthma. Allergy (2013) 1.48
European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design. Eur Respir J (1992) 1.47
Risk factors for atopic dermatitis in infants at high risk of allergy: the PIAMA study. Clin Exp Allergy (2003) 1.46
Mast cell numbers in airway smooth muscle and PC20AMP in asthma and COPD. Respir Med (2006) 1.45
The importance of serum IgE for level and longitudinal change in airways hyperresponsiveness in COPD. Clin Exp Allergy (1998) 1.44
Female mice are more susceptible to the development of allergic airway inflammation than male mice. Clin Exp Allergy (2005) 1.44
Indirect airway challenges. Eur Respir J (2003) 1.42
Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids. Clin Exp Allergy (1996) 1.41
[Efficacy of combined treatment with corticosteroids and beta2 agonists in adults with asthma]. Ned Tijdschr Geneeskd (2006) 1.40
Exclusion of chromosome 11q and the FcepsilonRI-beta gene as aetiological factors in allergy and asthma in a population of Dutch asthmatic families. Clin Exp Allergy (1998) 1.40
Mini-Wright peak flow meters are reliable after 5 years use. Dutch CNSLD Study Group. Eur Respir J (1997) 1.39
[Three patients with thoracic actinomycosis]. Ned Tijdschr Geneeskd (2008) 1.39
Mite-specific IgE cannot be used as a surrogate for mite exposure. Allergy (1995) 1.38
Effects of ambient air pollution on upper and lower respiratory symptoms and peak expiratory flow in children. Lancet (1999) 1.38
[The place of long-acting beta 2 adrenergic agonists in the treatment of asthma and chronic obstructive lung disease (COPD)]. Ned Tijdschr Geneeskd (1999) 1.37
The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease. Asthma Research Group. Am J Respir Crit Care Med (1999) 1.36
Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease. Thorax (1995) 1.35
Predictors of COPD symptoms: does the sex of the patient matter? Eur Respir J (2006) 1.34
Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid treatment. Dutch CNSLD Study Group. Eur Respir J (1993) 1.32
Cigarette smoke impairs airway epithelial barrier function and cell-cell contact recovery. Eur Respir J (2011) 1.32
Maternal overweight before pregnancy and asthma in offspring followed for 8 years. Int J Obes (Lond) (2009) 1.32
Adult patients may outgrow their asthma: a 25-year follow-up study. Am J Respir Crit Care Med (1997) 1.31
Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease. Thorax (1999) 1.30
Severity of obstructive airway disease and risk of osteoporotic fracture. Eur Respir J (2005) 1.27
Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group. Thorax (1994) 1.26
Toll-like receptor 2 and 4 genes influence susceptibility to adverse effects of traffic-related air pollution on childhood asthma. Thorax (2010) 1.24
Airway responsiveness to adenosine 5'-monophosphate in chronic obstructive pulmonary disease is determined by smoking. Am Rev Respir Dis (1993) 1.24
Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex. Thorax (2005) 1.23
MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy (2011) 1.22
Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life. Am J Respir Crit Care Med (2000) 1.18
Filaggrin mutations in the onset of eczema, sensitization, asthma, hay fever and the interaction with cat exposure. Allergy (2009) 1.18
Characterization of obstructive airway disease in family members of probands with asthma. An algorithm for the diagnosis of asthma. Am J Respir Crit Care Med (1998) 1.17
Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J (2000) 1.17